• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于肝细胞癌的基底膜相关免疫预后模型的开发与验证

Development and validation of a basement membrane-associated immune prognostic model for hepatocellular carcinoma.

作者信息

Ma Qiji, Wang Yun, Xing Jie, Wang Tielin, Wang Gang

机构信息

Department of Breast and Thyroid Surgery, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.

Department of Thoracic Surgery, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.

出版信息

Transl Gastroenterol Hepatol. 2025 Feb 23;10:28. doi: 10.21037/tgh-24-89. eCollection 2025.

DOI:10.21037/tgh-24-89
PMID:40337768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12056121/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC), one of the most common malignant tumors worldwide, has a poor prognosis primarily due to its invasive and metastatic characteristics. Cancer invasion through basement membrane (BM) is the pivotal initial step in tumor dissemination and metastasis. This study aimed to identify gene signatures associated with the BM to enhance the overall prognosis of HCC.

METHODS

In this study, we performed multiple bioinformatics analyses based on the RNA sequencing (RNA-seq) data and clinical information from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets. An unsupervised consistent cluster analysis was conducted on 370 HCC patients, categorizing them into two distinct groups based on the expression profiles of 222 BM-related genes. Differentially expressed genes (DEGs) between these clusters were identified, followed by functional enrichment analysis. To explore the differences between the groups, the Estimation of STromal and Immune cells in MAlignant Tumours using Expression data (ESTIMATE) and Cell type Identification By Estimating Relative Subsets Of known RNA Transcripts (CIBERSORT) algorithms were applied, along with the analysis of immune checkpoint molecules and human leukocyte antigen (HLA) expression levels. This helped in understanding the relationship between the HCC immune microenvironment and BM-related genes. A prognostic model was constructed using univariate Cox and least absolute shrinkage and selection operator (LASSO) regression analyses, with its performance subsequently estimated and validated. Additionally, hub biomarkers genes were identified using machine learning techniques, followed by an analysis of their functions and relationships with clinical characteristics. Finally, single-cell clustering analysis was employed to further investigate the expression distribution of these genes within the HCC immune microenvironment.

RESULTS

Following consistent cluster analysis, two groups were identified: the BM high group and the BM low group. Among the 6,221 DEGs between the two groups, 5,863 were upregulated and 358 were downregulated, with enrichment functions primarily associated with extracellular matrix (ECM) organization, cell adhesion, immune response, and metabolism. The expression levels of BM-related genes were found to regulate the HCC immune microenvironment. Using univariate Cox regression analysis, 60 prognostic BM-related genes were identified, leading to the establishment of an 11-gene prognostic model named BMscore to predict the overall survival (OS) of HCC patients. The high BMscore group indicated worse prognosis, and the model's predictive performance was validated using the GEO dataset. and were identified as hub biomarkers, playing roles in cell proliferation and ECM metabolism, with their expression distributions mapped respectively.

CONCLUSIONS

A prognostic model based on BM-related genes was successfully developed and shows promise for evaluating prognoses and offering personalized treatment recommendations.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/1ab44177ae12/tgh-10-24-89-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/a96b376e33b1/tgh-10-24-89-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/ff507b9dbf3d/tgh-10-24-89-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/452cd061e0d6/tgh-10-24-89-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/a0caf19f6ab7/tgh-10-24-89-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/1c2dd285dd83/tgh-10-24-89-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/57b0920bf3fc/tgh-10-24-89-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/1ab44177ae12/tgh-10-24-89-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/a96b376e33b1/tgh-10-24-89-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/ff507b9dbf3d/tgh-10-24-89-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/452cd061e0d6/tgh-10-24-89-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/a0caf19f6ab7/tgh-10-24-89-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/1c2dd285dd83/tgh-10-24-89-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/57b0920bf3fc/tgh-10-24-89-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac25/12056121/1ab44177ae12/tgh-10-24-89-f7.jpg
摘要

背景

肝细胞癌(HCC)是全球最常见的恶性肿瘤之一,其预后较差,主要归因于其侵袭和转移特性。肿瘤通过基底膜(BM)的侵袭是肿瘤播散和转移的关键起始步骤。本研究旨在识别与基底膜相关的基因特征,以改善HCC的总体预后。

方法

在本研究中,我们基于来自癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)数据集的RNA测序(RNA-seq)数据及临床信息进行了多项生物信息学分析。对370例HCC患者进行无监督一致性聚类分析,根据222个与基底膜相关基因的表达谱将他们分为两个不同的组。识别这些聚类之间的差异表达基因(DEG),随后进行功能富集分析。为探究两组之间的差异,应用了利用表达数据估计恶性肿瘤中的基质和免疫细胞(ESTIMATE)算法以及通过估计已知RNA转录本的相对子集进行细胞类型鉴定(CIBERSORT)算法,同时分析免疫检查点分子和人类白细胞抗原(HLA)的表达水平。这有助于了解HCC免疫微环境与基底膜相关基因之间的关系。使用单变量Cox回归和最小绝对收缩和选择算子(LASSO)回归分析构建预后模型,随后对其性能进行估计和验证。此外,利用机器学习技术识别枢纽生物标志物基因,接着分析它们的功能以及与临床特征的关系。最后,采用单细胞聚类分析进一步研究这些基因在HCC免疫微环境中的表达分布。

结果

经过一致性聚类分析,识别出两组:基底膜高表达组和基底膜低表达组。两组之间的6221个差异表达基因中,5863个上调,358个下调,富集功能主要与细胞外基质(ECM)组织、细胞黏附、免疫反应和代谢相关。发现基底膜相关基因的表达水平调节HCC免疫微环境。通过单变量Cox回归分析,识别出60个与预后相关的基底膜相关基因,从而建立了一个名为BMscore的11基因预后模型,用于预测HCC患者的总生存期(OS)。BMscore高的组预后较差,该模型的预测性能在GEO数据集上得到验证。 和 被识别为枢纽生物标志物,在细胞增殖和ECM代谢中发挥作用,并分别绘制了它们的表达分布图。

结论

成功开发了一种基于基底膜相关基因的预后模型,该模型在评估预后和提供个性化治疗建议方面显示出前景。

相似文献

1
Development and validation of a basement membrane-associated immune prognostic model for hepatocellular carcinoma.一种用于肝细胞癌的基底膜相关免疫预后模型的开发与验证
Transl Gastroenterol Hepatol. 2025 Feb 23;10:28. doi: 10.21037/tgh-24-89. eCollection 2025.
2
Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.基于单样本基因集富集分析(ssGSEA)算法的免疫相关基因特征在肝细胞癌预后及免疫格局中的综合分析
Front Genet. 2022 Dec 9;13:1064432. doi: 10.3389/fgene.2022.1064432. eCollection 2022.
3
Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.转移和基底膜相关特征通过整合单细胞RNA测序分析和免疫微环境评估增强肝细胞癌的预后和诊断。
J Transl Med. 2024 Jul 31;22(1):711. doi: 10.1186/s12967-024-05493-0.
4
Identification and validation of a novel innate lymphoid cell-based signature to predict prognosis and immune response in liver cancer by integrated single-cell RNA analysis and bulk RNA sequencing.通过整合单细胞RNA分析和批量RNA测序鉴定并验证一种基于新型固有淋巴细胞的特征,以预测肝癌的预后和免疫反应。
Transl Cancer Res. 2024 Oct 31;13(10):5395-5416. doi: 10.21037/tcr-24-725. Epub 2024 Oct 28.
5
A novel basement membrane-related gene signature for prognosis of lung adenocarcinomas.一个与基底膜相关的新型基因特征可用于预测肺腺癌的预后。
Comput Biol Med. 2023 Mar;154:106597. doi: 10.1016/j.compbiomed.2023.106597. Epub 2023 Jan 24.
6
Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.鉴定调控肝癌肿瘤免疫微环境和预后的 COVID-19 关键基因。
Funct Integr Genomics. 2023 Aug 4;23(3):262. doi: 10.1007/s10142-023-01184-z.
7
The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.鉴定 N6-甲基腺苷相关的 microRNA 预测肝细胞癌的预后和免疫治疗疗效。
Cancer Biomark. 2023;38(4):551-566. doi: 10.3233/CBM-230263.
8
Multi-omics identification of a polyamine metabolism related signature for hepatocellular carcinoma and revealing tumor microenvironment characteristics.多组学鉴定肝细胞癌中与多胺代谢相关的特征并揭示肿瘤微环境特征
Front Immunol. 2025 Apr 22;16:1570378. doi: 10.3389/fimmu.2025.1570378. eCollection 2025.
9
Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.线粒体相关转录组特征与肝细胞癌的预后、血管侵犯、肿瘤微环境和治疗反应相关。
Oxid Med Cell Longev. 2022 Apr 30;2022:1592905. doi: 10.1155/2022/1592905. eCollection 2022.
10
Expression of lipid-metabolism genes is correlated with immune microenvironment and predicts prognosis of hepatocellular carcinoma.脂质代谢基因的表达与免疫微环境相关,并可预测肝细胞癌的预后。
Sci Rep. 2024 Oct 28;14(1):25705. doi: 10.1038/s41598-024-76578-5.

本文引用的文献

1
Pan-Cancer Analysis of P3H1 and Experimental Validation in Renal Clear Cell Carcinoma.泛癌症分析 P3H1 及其在肾透明细胞癌中的实验验证。
Appl Biochem Biotechnol. 2024 Sep;196(9):5974-5993. doi: 10.1007/s12010-023-04845-8. Epub 2024 Jan 4.
2
Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database.基于癌症基因组图谱数据库鉴定P3H1作为膀胱尿路上皮癌的预测性预后生物标志物
Pharmgenomics Pers Med. 2023 Dec 1;16:1041-1053. doi: 10.2147/PGPM.S437974. eCollection 2023.
3
Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion.
伴有微血管侵犯的肝细胞癌的术后辅助治疗
World J Gastrointest Surg. 2023 Jan 27;15(1):19-31. doi: 10.4240/wjgs.v15.i1.19.
4
A prognostic and therapeutic hallmark developed by the integrated profile of basement membrane and immune infiltrative landscape in lung adenocarcinoma.肺腺癌中基底膜和免疫浸润景观的综合特征所形成的预后和治疗标志物。
Front Immunol. 2022 Nov 30;13:1058493. doi: 10.3389/fimmu.2022.1058493. eCollection 2022.
5
Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.肾透明细胞癌中基底膜的特征分析以指导临床治疗。
Front Oncol. 2022 Nov 10;12:1024956. doi: 10.3389/fonc.2022.1024956. eCollection 2022.
6
Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead-A Systematic Review.针对肝细胞癌治疗的靶向治疗:新时代的到来——系统评价。
Int J Mol Sci. 2022 Nov 15;23(22):14117. doi: 10.3390/ijms232214117.
7
Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients.基底膜基因在透明细胞肾细胞癌患者中的表达及其预后意义
Front Oncol. 2022 Oct 24;12:1026331. doi: 10.3389/fonc.2022.1026331. eCollection 2022.
8
Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer.膀胱癌中基底膜相关长链非编码RNA的预后意义及鉴定
Front Oncol. 2022 Oct 10;12:994703. doi: 10.3389/fonc.2022.994703. eCollection 2022.
9
A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma.一种新定义的用于透明细胞肾细胞癌预后的基底膜相关基因特征。
Front Genet. 2022 Sep 15;13:994208. doi: 10.3389/fgene.2022.994208. eCollection 2022.
10
A basement membrane discovery pipeline uncovers network complexity, regulators, and human disease associations.基底膜发现管道揭示了网络复杂性、调控因子和人类疾病的关联。
Sci Adv. 2022 May 20;8(20):eabn2265. doi: 10.1126/sciadv.abn2265. Epub 2022 May 18.